Expression of chemokine receptor CXCR3 on cerebrospinal fluid T-cells is related to active MRI lesion appearance in patients with relapsing-remitting multiple sclerosis

被引:36
作者
Sindern, E
Patzold, T
Ossege, LM
Gisevius, A
Malin, JP
机构
[1] Ruhr Univ Bochum, BG Kliniken Bergmannsheil, Dept Neurol, D-44789 Bochum, Germany
[2] Ruhr Univ Bochum, BG Kliniken Bergmannsheil, Dept Radiol, D-44789 Bochum, Germany
关键词
multiple sclerosis; T-cells; CXCR3; CXCL10; magnetic resonance imaging;
D O I
10.1016/S0165-5728(02)00263-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
We evaluated CXCR3 expression on T-cells and levels of its ligand CXCL10 in blood and cerebrospinal fluid (CSF) of 22 patients with relapsing-remitting multiple sclerosis (RR-MS) in association with magnetic resonance imaging (MRI) disease activity. CXCL10 was strongly released intrathecally, but did not change in association with MRI activity. CXCR3 expression on T-cells was lower in the peripheral blood (PB) of RR-MS patients compared to healthy controls and was increased in the CSF of RR-MS patients undergoing acute attacks, as illustrated by Gd-enhancing lesions on MRI, compared to patients without enhancing lesion. Our results suggest that MRI-documented disease activity is associated with an increase of CXCR3 positive T-cells in the CSF, possibly due to the migration of activated T-cells from the circulation into the CSF. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:186 / 190
页数:5
相关论文
共 10 条
[1]
CCR5+ and CXCR3+ T cells are increased in multiple sclerosis and their ligands MIP-1α and IP-10 are expressed in demyelinating brain lesions [J].
Balashov, KE ;
Rottman, JB ;
Weiner, HL ;
Hancock, WW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (12) :6873-6878
[2]
Chemokines - Chemotactic cytokines that mediate inflammation [J].
Luster, AD .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (07) :436-445
[3]
Chemokine receptor expression on T cells in blood and cerebrospinal fluid at relapse and remission of multiple sclerosis: imbalance of Th1/Th2-associated chemokine signaling [J].
Misu, T ;
Onodera, H ;
Fujihara, K ;
Matsushima, K ;
Yoshie, O ;
Okita, N ;
Takase, S ;
Itoyama, Y .
JOURNAL OF NEUROIMMUNOLOGY, 2001, 114 (1-2) :207-212
[4]
PANITCH HS, 1987, LANCET, V1, P893
[5]
Mechanisms of inflammation in MS tissue: adhesion molecules and chemokines [J].
Ransohoff, RM .
JOURNAL OF NEUROIMMUNOLOGY, 1999, 98 (01) :57-68
[6]
Expression of the interferon-γ-inducible chemokines IP-10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions [J].
Simpson, JE ;
Newcombe, J ;
Cuzner, ML ;
Woodroofe, MN .
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2000, 26 (02) :133-142
[7]
Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients [J].
Sorensen, TL ;
Tani, M ;
Jensen, J ;
Pierce, V ;
Lucchinetti, C ;
Folcik, VA ;
Qin, SX ;
Rottman, J ;
Sellebjerg, F ;
Strieter, RM ;
Frederiksen, JL ;
Ransohoff, RM .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (06) :807-815
[8]
Investigating chemokines and chemokine receptors in patients with multiple sclerosis - Opportunities and challenges [J].
Trebst, C ;
Ransohoff, RM .
ARCHIVES OF NEUROLOGY, 2001, 58 (12) :1975-1980
[9]
Chemokines and chemokine receptors in the pathogenesis of multiple sclerosis [J].
Zhang, GX ;
Baker, CM ;
Kolson, DL ;
Rostami, AM .
MULTIPLE SCLEROSIS JOURNAL, 2000, 6 (01) :3-13
[10]
Chemokines: A new classification system and their role in immunity [J].
Zlotnik, A ;
Yoshie, O .
IMMUNITY, 2000, 12 (02) :121-127